The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
Parliamentary panel slams drug pricing regulator for hike on 11 drugs used for treating conditions such as asthma, glaucoma, ...
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
India’s NPPA is under fire for approving a 50% hike on 11 drug formulations, raising concerns about the impact on vulnerable ...
The global industrial hvac market size is estimated to grow by USD 6.81 billion from 2025 to 2029, according to Technavio.
One could be forgiven for feeling the same way about the current world of drug delivery devices, with an increasingly ...
As part of the agreement, Akums Group will receive an upfront payment of €100 million (INR 880 crores) for product ...
CMOs must invest in regular maintenance and upgrades to maintain their competitive edge. Labor is a significant cost for CMOs. They must hire and train skilled personnel to manage various aspects of ...
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
The subjects in the study were given a single 50mg dose of CTx-1301, Cingulate’s highest dosage, to determine if the medication can be taken in fed and fasted states. No serious adverse events were ...
Quabodepistat is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Pulmonary Tuberculosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback